FIELD: organic chemistry, medicine, pharmacology. SUBSTANCE: invention proposes the novel agent for SUPPRESSION of skin or vagina atrophy. This agent acting by activation and/or SUPPRESSION of gene by raloxifen-estrogen receptor complex is the compound of the formula: where: R1 and R3 mean independently each of other hydrogen atom, methyl, or where Ar is optionally substituted phenyl; R2 is taken among the group including pyrrolidine, piperidine and hexamethyleneamine, or its pharmaceutically acceptable salts. EFFECT: enhanced effectiveness of the method. 4 cl, 18 comp
Authors
Dates
2000-01-10—Published
1994-12-19—Filed